Abstract:In this study, genes associated with the Notch signaling pathway in gliomas were analyzed using bioinformatics and in vitro experiments. The dataset GSE22772 was downloaded from the Gene-Cloud of Biotechnology Information database. Differentially expressed genes (DEGs) between short hairpin RNA (shRNA) intervening glioma cells and control cells were screened using the unpaired t test. Functional enrichment analysis was performed, and coexpression network was analyzed to identify the most important genes associated with the Notch signaling pathway. Integrin beta 1 (ITGB1) mRNA and protein levels in clinical glioma tumor samples and tumor adjacent normal tissue samples were analyzed using quantitative real-time PCR and immunohistochemistry, respectively. The relationship between ITGB1 expression and the prognosis of patients with gliomas was analyzed using the Kaplan-Meier curve. ITGB1 interference expression cell line U87 and ITGB1 overexpressing cell line were established using sh-ITGB1 and oe-ITGB1 plasmids, respectively. MTT and colony formation assays were used to detect changes in the proliferation of glioma cells. Moreover, western blotting was used to detect the expression of Notch and Hey1. A total of 7,962 DEGs were screened between shRNA intervening glioma cells and control cells, which were mainly associated with spliceosome, proteoglycans in cancer, focal adhesion, and the Notch signaling pathway. ITGB1 showed the highest expression in the coexpression network. The mRNA and protein expression of ITGB1 in glioma tumor samples was significantly higher than that in tumor adjacent normal tissue samples ( p < 0.05 ). Overall survival time of patients in the ITGB1 low-expression group was significantly longer than that in the ITGB1 high-expression group, indicating that ITGB1 expression negatively correlated with the prognosis. Fluorescence microscopy, qRT-PCR, and western blotting confirmed the transfection efficiency of ITGB1 overexpression and interference expression in U251 and U87 cells. The MTT and colony formation assays indicated that U87 cell proliferation was significantly inhibited after intervention with ITGB1 ( p < 0.05 ), and overexpression of ITGB1 significantly promoted U251 cell proliferation ( p < 0.05 ). In addition, the expression of Notch and Hey1 proteins was significantly decreased after ITGB1 intervention ( p < 0.05 ), and their expression was significantly upregulated after ITGB1 overexpression ( p < 0.05 ). ITGB1 expression in glioma tissues was significantly higher than that in adjacent normal tissues and was negatively correlated with the survival time of patients. Therefore, ITGB1 can significantly promote proliferation of glioma cells via feedback regulation of the Notch signaling pathway.

Interferon-beta inhibits human glioma stem cell growth by modulating immune response and cell cycle related signaling pathways

Interferon-β exposure induces a fragile glioblastoma stem cell phenotype with a transcriptional profile of reduced migratory and MAPK pathway activity

Primary study of growth inhibition and cytokine regulation effect of interferon-β(IFN-β) on glioma cell line SK-MG-1

Glioma Stem-Like Cells Evade Interferon Suppression Through MBD3/NuRD Complex-Mediated STAT1 Downregulation

Immu-72. Type I Interferon Signaling Within Glioblastoma Cells Promotes T-Cell Exhaustion And Resistance To Checkpoint Inhibitors

C6 glioma cells were inhibited by mesenchymal stem cells(MSCs) transfected with the Beta-interferon gene in vitro

Neural Stem Cell-Derived Factors Inhibit the Growth and Invasion of U87 Stem-Like Cells in Vitro

The Inhibiting Effect of Neural Stem Cells on Proliferation and Invasion of Glioma Cells.

Effects of Transforming Growth Factor-Β Inhibitor on the Proliferation of Glioma Stem/progenitor Cell.

Bone Marrow-Derived Mesenchymal Stem Cells Co-Expressing Interleukin-18 and Interferon-Β Exhibit Potent Antitumor Effect Against Intracranial Glioma in Rats.

IGFBP2 promotes neural stem cell maintenance and proliferation differentially associated with glioblastoma subtypes

Effect of the Interference with DRP1 Expression on the Biological Characteristics of Glioma Stem Cells

Effect of Interferon-Α/β on Temozolomide Activity Against MGMT-positive Glioma Stem-Like Cells in Vitro and in Vivo.

Interferon-α/β Enhances Temozolomide Activity Against MGMT-positive Glioma Stem-Like Cells

Construction of Interferon-Gamma-Related Gene Signature to Characterize the Immune-Inflamed Phenotype of Glioblastoma and Predict Prognosis, Efficacy of Immunotherapy and Radiotherapy

Type I interferon signaling regulates myeloid and T cell crosstalk in the glioblastoma tumor microenvironment

The Crosstalk between the EGFR and IFN-γ Pathways and Synergistic Roles in Survival Prediction and Immune Escape in Gliomas

Human neural stem cells repress glioma cell progression in a paracrine manner by downregulating the Wnt/β-catenin signalling pathway

Effect of glioma-derived immunoglobulin on biological function of glioma cells

Targeting Interleukin 6 Signaling Suppresses Glioma Stem Cell Survival and Tumor Growth.

Integrin Beta 1 Promotes Glioma Cell Proliferation by Negatively Regulating the Notch Pathway